Time To ACT reports 21% revenue growth in fiscal 2025

Time To ACT plc (AQSE:TTA), an energy transition technology group, reported a 21% increase in annual revenue to £2.28 million for FY2025, alongside an improved gross profit margin of 47% and a reduced adjusted EBITDA loss of £618,741, demonstrating resilience amid global project delays. The company, which saw growing revenues from its hydrogen sector, subsequently raised £274,000 in May 2025 and maintains its £3.5 million sales target for the current fiscal year by securing replacement revenues.

Analysis

Time To ACT plc (AQSE:TTA) demonstrated notable top-line momentum in its fiscal year 2025 results, reporting a 21% increase in revenue to £2.28 million and an improved gross profit margin of 47%, up from 43% in the prior year. This growth, driven partly by contracts in the hydrogen sector, was achieved despite what management described as a challenging global environment with project delays, suggesting a degree of operational resilience. While the company remains unprofitable, it has shown progress in cost management, narrowing its adjusted EBITDA loss to £618,741 from £888,374. However, a significant concern is the balance sheet, as cash holdings decreased sharply to £964,555 from £1.89 million, indicating a substantial cash burn rate. A post-period capital raise of £274,000 provides some near-term liquidity but appears modest relative to the previous year's cash outflow. Management's confidence is underscored by its maintained sales target of £3.5 million for the current fiscal year, which hinges on securing replacement revenues to offset known project delays.

Key Decisions for Investors

• Investors should weigh the company's strong revenue growth and strategic positioning in the high-potential hydrogen and renewable energy sectors against the considerable risks associated with its unprofitability and significant cash burn.
• The sharp reduction in cash reserves is a primary risk factor; therefore, it is critical to monitor the company's liquidity, burn rate, and ability to secure additional, more substantial financing beyond the recent £274,000 raise.
• The reiterated sales target of £3.5 million for the current year is an ambitious benchmark, and investors should scrutinize upcoming trading updates for tangible evidence of progress, particularly regarding the 'replacement revenues' cited by management.